Results 151 to 160 of about 54,328 (210)
Comparative effectiveness of dopamine agonists and monoamine oxidase type-B inhibitors for Parkinson's disease: a multiple treatment comparison meta-analysis. [PDF]
Binde CD+4 more
europepmc +1 more source
Non-ergot dopamine agonists and heart failure. [PDF]
Şener YZ, Okşul M, Çöteli C.
europepmc +1 more source
Tolerability of non-ergot oral and transdermal dopamine agonists in younger and older Parkinson's disease patients: an European multicentre survey. [PDF]
Rizos A+11 more
europepmc +1 more source
Metabolic effects of dopamine agonists in patients with prolactinomas: a systematic review and meta-analysis. [PDF]
Byberg S+3 more
europepmc +1 more source